Mesenchymal stromal cells administration for osteonecrosis of the jaw caused by bisphosphonate: report of two cases

References

• Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003;61:1115–1117.
   PubMed Web of Science ®Google Scholar
• Ryan P, Saleh I, Stassen L. Osteonecrosis of the jaw: a rare and devastating side effect of bisphosphonates. Postgrad Med J. 2009;85:674–677.
   PubMed Web of Science ®Google Scholar
• Mhaskar R, Kumar A, Miladinovic B, et al. Bisphosphonates in multiple myeloma: an updated network meta-analysis. Cochrane Database Syst Rev. 2017;12:CD003188.
   PubMed Web of Science ®Google Scholar
• O’Carrigan B, Wong MH, Willson ML, et al. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev. 2017;10:CD003474.
   PubMed Web of Science ®Google Scholar
• Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet. 2019;393:364–376.
   PubMed Web of Science ®Google Scholar
• Fleisch H, Fast D, Rizzoli R, et al. Diphosphonates. Mode of action and clinical applications. Adv Exp Med Biol. 1977;81:279–289.
   PubMedGoogle Scholar
• Otto S, Pautke C, Van den Wyngaert T, et al. Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev. 2018;69:177–187.
   PubMed Web of Science ®Google Scholar
• Saad F, Brown JE, Van Poznak C, et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol. 2012;23:1341–1347.
   PubMed Web of Science ®Google Scholar
• Nisi M, La Ferla F, Karapetsa D, et al. Conservative surgical management of patients with bisphosphonate-related osteonecrosis of the jaws: a series of 120 patients. Br J Oral Maxillofac Surg. 2016;54:930–935.
   PubMed Web of Science ®Google Scholar
• Silva LF, Curra C, Munerato MS, et al. Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg. 2016;20:9–17.
   PubMedGoogle Scholar
• Curi MM, Cossolin GS, Koga DH, et al. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg. 2007;65:349–355.
   PubMed Web of Science ®Google Scholar
• Hernigou P, Beaujean F. Treatment of osteonecrosis with autologous bone marrow grafting. Clin Orthop Relat Res. 2002;(405):14–23.
   PubMed Web of Science ®Google Scholar
• Andriolo L, Merli G, Tobar C, et al. Regenerative therapies increase survivorship of avascular necrosis of the femoral head: a systematic review and meta-analysis. Int Orthop. 2018;42:1689–1704.
   PubMed Web of Science ®Google Scholar
• Dos Santos VT, Mizukami A, Orellana MD, et al. Characterization of human AB serum for mesenchymal stromal cell expansion. Transfus Med Hemother. 2017;44:11–21.
   PubMed Web of Science ®Google Scholar
• de Lima Prata K, de Santis GC, Orellana MD, et al. Cryopreservation of umbilical cord mesenchymal cells in xenofree conditions. Cytotherapy. 2012;14:694–700.
   PubMed Web of Science ®Google Scholar
• Barba-Recreo P, Del Castillo Pardo de Vera JL, Georgiev-Hristov T, et al. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model. J Craniomaxillofac Surg. 2015;43:1161–1168.
   PubMed Web of Science ®Google Scholar
• Ristow O, Rückschloß T, Müller M, et al. Is the conservative non-surgical management of medication-related osteonecrosis of the jaw an appropriate treatment option for early stages? A long-term single-center cohort study. J Craniomaxillofac Surg. 2019;47:491–499.
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Dodson TB, Fantasia J, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg. 2014;72 :1938–1956.
   PubMed Web of Science ®Google Scholar
• Lopes RN, Rabelo GD, Rocha AC, et al. Surgical therapy for bisphosphonate-related osteonecrosis of the jaw: six-year experience of a single institution. J Oral Maxillofac Surg. 2015;73:1288–1295.
   PubMed Web of Science ®Google Scholar
• Abu-Id MH, Warnke PH, Gottschalk J, et al. Bis-phossy jaws” - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg. 2008;36:95–103.
   PubMed Web of Science ®Google Scholar
• Noronha NC, Mizukami A, Caliári-Oliveira C, et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies. Stem Cell Res Ther. 2019;10:131.
   PubMed Web of Science ®Google Scholar
• Valenti MT, Dalle Carbonare L, Mottes M. Osteogenic differentiation in healthy and pathological conditions. IJMS. 2016;18:41.
   Web of Science ®Google Scholar
• Papakostidis C, Tosounidis TH, Jones E, et al. The role of “cell therapy” in osteonecrosis of the femoral head. A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop. 2016;87:72–78.
   PubMed Web of Science ®Google Scholar
• Aoyama T, Goto K, Kakinoki R, et al. An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts. Tissue Eng Part B Rev. 2014;20:233–242.
   PubMed Web of Science ®Google Scholar
• Cella L, Oppici A, Arbasi M, et al. Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw. Head Face Med. 2011;7:16.
   PubMed Web of Science ®Google Scholar
• Voss PJ, Matsumoto A, Alvarado E, et al. Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells. Odontology. 2017;105:484–493.
   PubMed Web of Science ®Google Scholar
• Kaibuchi N, Iwata T, Onizuka S, et al. Allogeneic multipotent mesenchymal stromal cell sheet transplantation promotes healthy healing of wounds caused by zoledronate and dexamethasone in canine mandibular bones. Regen Ther. 2019;10:77–83.
   PubMed Web of Science ®Google Scholar